The late Dr.Joe Selkon, eminent Microbiologist, and mentor to Charles Cocking, HOCl Trust's Founder. Image source: histmodbiomed.org
Sodium Dichloroisocyanurate (NaDCC)
Solutions of NaDCC release "free" available chlorine (av.Cl2) in the form of HOCl (Hypochlorous acid) and OCl (Hypochlorite), in 50:50 equilibrium with the "combined" available chlorines, mono- and dichloroisocyanurate. According as the free chlorine becomes used up by micro-organisms and organic matter etc., the combined will release further free av.Cl2 to restore the 50:50 balance. This will continue with increasing demand until no further chlorine remains available. This is a unique phenomenon among chlorine donor compounds and explains:
a) The greater biocidal capacity of NaDCC;
b) Why NaDCC is less toxic and less corrosive; and
c) Why NaDCC solutions persist for much longer, and in an active state.
It is generally believed that the antimicrobial activity of NaDCC is due to chlorination of cell protein or enzyme systems by free HOCl, causing hydrolysis of the peptide chains of the micro-organisms' cell membranes.
pH has probably the greatest influence on the disinfectant activity of all chlorine solutions and the HOCl ion is responsible for the microbiocidal activity of NaDCC solutions. Hypochlorous acid dissociates eventually as follows:- HOCl to H+ + OCl- ; with HOCl possessing 100 times greater potency than OCl (hypochlorites).
This Dissociation of HOCl is critically pH dependent:
At pH5: abt. 99.7 % HOCl is released from solutions of NaDCC. At pH7 (Pure Water): abt. 72.3% At pH 9.5 (average for sodium hypochlorite solutions) a mere 0.19% HOCl is yielded up.
This helps to explain the significant advantage in microbiocidal activity of NaDCC based products over all other chlorine donors.
It is important to remember that:-
NaDCC products are active over a pH range of 5.0 - 6.5.
They differ totally from hypochlorites and chloramines Hypochlorites (bleach) and Chloramines are effective only at alkaline pH (av. 9.5), releasing minimal or relatively low levels of HOCl compared to NaDCC-based compounds.
NaDCC products release highly significant levels of HOCl.
a) More effective
b) less toxic and less corrosive than other chlorine compounds, with
c) rapid HOCl release
d) rapid biocidal activity
e) no skin irritation.
Smell: The faint, characteristic "chlorine" smell from all NaDCC solutions is due to the release of chloramines (breakdown products of NaDCC). The scent becomes more pronounced as organic substances like skin, micro-organisms or any organic contamination load come into contact with NaDCC solutions.
Includes:
Actinobacillus sp.
Actinomyces pyogenes
Bacillus anthracis
Brucella abortus
Clostridium butyricum
Clostridium sp.
Corynebacterium sp. Enterobacter cloacae
Enterobacter sp.
Eschericia coli
Escheria coli 0157-H
Erysipelothrix sp
Klebsiella sp.
Legionella pneumophilia Leptospira sp.
Listeria monocytogenes
Mycobacterium paratuberculosis
Mycobacterium smegmatis
Mycobacterium sp.
Mycobacterium terrae 232 Mycobacterium
tuberculosis ATCC25618
Mycoplasma mycoides
Mycoplasma sp.
Norcardia sp.
Pasteurella sp.
Proteus vulgaris
Pseudomonas aeruginosa NCTC6749
Pseudomonas aeureus
Pseudomonas fluorescens IM
Rhodococcus equi.
Salmonella dysenteriae
Salmonella typhimurium
Salmonella typhimurium phage type 104
Salmonella typhosa
Shigella sonnei
Staphylococcus agalactiae
Staphylococcus aureus
Methicillin Resistant Staphylococcus aureus - MRSA
Staphylococcus dysgalactiae
Staphylococcus uberis
Streptococcus equi.
Vibrio sp.
Adeno virus 3,7,7a,8 & 12
Aujesky's virus
Bovine Viral Diarrhoea virus (BVD)
Coronavirus
Coxsackie A2 (Purified)
Creutzfeldt-Jakob Disease virus
Distemper virus
Echovirus
Equine Herpes virus (1 & 4)
Equine Influenza virus
Foot & Mouth Disease virus
Hardpad virus
Hepatitis A virus
Hepatitis B virus
Infectious hepatitis virus
Herpes Simplex virus 1
Human Rotavirus
Human Immunodeficiency virus (HIV)
HIV + 10% plasma HIV in contaminated blood
Newcastle Disease virus
Parvovirus
Poliovirus 1, 2 & 3
Reovirus 1,2 & 3
Respiratory Syncitial virus (RSV)
Rotavirus
Simian Rotavirus SA11 (Purified)
Theiler's virus (Purified)
Bacillus anthracis spores
Bacillus cereus spores
Bacillus globigii spores
Bacillus subtilis spores
Clostridium bifermentans spores
Clostridium butyricum spores
Clostridium histolyticum spores
Clostridium histolyticum spores 503 Clostridium
sporogenes spores
Clostridium tetani spores
Tubercule bacilli spores
Fungi/Yeasts:
Aspergillus fumigatus
Aspergillus niger
Candida albicans
Cryptococcus sp
Fusarium sp
Microsporum sp
Mucor sp Penicillium sp
Saccharomyces sp
Trichophyton sp
Dr. J.B. Selkon - Oxford University and John Radcliffe Hospital
Dr Joe Selkon died in March 2013. However he was fully supportive for the entire duration of our work together on HOCl since 1994. He bequeathed all his personal files to Charles Cocking and requested he continue to use his data to further the research.
Dr. Stephen P. Barrett - Consultant Medical Microbiologist, Department of Medical Microbiology, Imperial College at St. Mary's Hospital, London. Deputy Editor, Journal of Hospital Infection.
Dr. Iwona Beech - B.Sc.Ph.D.C.Chem. Research Professor University of Oklahoma, Department of Microbiology & Plant Biology, GLCH, 770 Van Vleet Oval, Norman, OK 73019, USA.
Dr. Carlton Evans - Imperial College and London School of Hygiene and Tropical Medicine.
Dr. Edwin Prince (retired) - University of Central Lancashire. National Board of Expert Witnesses.
Dr. Martin Fulford - BDS. MPhil. DGDP. FIBMS.
Dr. Hugh Martin - BSc (London), MSc (Imperial), PhD (London), DIC - Royal Agricultural College, Cirencester. Principle Lecturer – Agricultural Science.
Dr Ginny Moore - Biosafety Investigation Unit, Public Health England, Porton Down, Salisbury, Wiltshire.
Selection of Peer Review Papers on HOCl
1. British Dental Journal 198, 353 - 354 (2005) Published online: 26 March 2005 | doi:10.1038/sj.bdj.4812174. An investigation of the efficacy of super–oxidised (Optident/Sterilox) water for the disinfection of dental unit water lines.
2. V. Zinkevich, I.B. Beech, R. Tapper, I. Bogdarnia (2000) Journal of Hospital Infection 46: 153-156; The effect of HOCl on Escherichia coli.
3. H. Hays, P.R. Elliker and W.E. Sandine (1966) Applied Microbiology, page 575-581; Microbial Destruction by Low Concentrations of Hypochlorite and lodophor Germicides in Alkaline and Acidified Water.
4. I.B. Beech, V. Zinkevich, J.A. Sunner, C.C. Gaylarde (2007) Technical Report; Evaluation of the effect of Salvox (Stabilised HOCl) on Planktonic Populations of model marine bacteria: Aerobic slime forming bacterium of the Pseudomonas Genus and anaerobic sulphate-reducing bacterium Desulfovibrio alaskensis.
5. J.B. Selkon, G.W. Cherry, J.M. Wilson, M.A. Hughes (2006) Evaluation of Hypochlorous Acid washes in the treatment of chronic venous leg ulcers.
6. N. Shetty, S. Srinivasan, J. Holton, G.L. Ridgway, J.B. Selkon (1997) Evaluation of Microbiocidal activity of a new disinfectant; against vegetative Bacteria, Spores, Candida albicans, Mycobacterium species.
7. N. Shetty, S. Srinivasan, J. Holton and G.L. Ridgway (1999) Journal of Hospital Infection 41:101-105 Evaluation of microbiocidal activity of a new disinfectant: HOCl against Clostridium difficile spores, Helicobacter pylori, vancomycin resistant Enterococcus species, Candida albicans and several Mycobacterium species.
7. J.B. Selkon, R.B. Babb, R. Morris (1999) Evaluation of the antimicrobial activity of a new super-oxidised water, HOCl for the disinfection of endoscopes.
8. J.B. Selkon, A. Crossley (2009) Analysis of Hypochlorous Acid.
9. J. Lorrain Smith, A. Murray Drennan, Theodore Rettie and William Campbell. Experimental Observations on the antiseptic action of Hypochlorous Acid and its application to wound treatment. Br Med J Jul 1915; 2: 129 – 136; doi:10.1136 bmj.2.2847.129.
10. Wang L, Bassiri M et al. Journal of Burns and Wounds April 11th 2007 pp 65-79. Hypochlorous Acid as a potential wound care agent.
11. Granum, Magnusson. International journal of food microbiology 1987 page 183-186. The effect of pH on hypochlorite as a disinfectant.
12. J. Clark, S. P. Barrett, M. Rogers and R. Stapleton. Department of Microbiology, Charing Cross Hospital, London, UK 2 July 2006 Efficacy of super-oxidized water fogging in environmental decontamination.
13. Ramalingam S, Cai B, Wong J, Twomey M, Chen R, Fu RM, Boote T, McCaughan H, Griffiths SJ, Haas JG. Sci Rep. 2018 Sep. 11. Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels.
14. Jeffrey Williams, Eric Rasmussen, Lori Robins October 6, 2017 Infectioncontrol.tips: Hypochlorous Acid: Harnessing an Innate Response
15. Hakimullah HAKIM, Md. Shahin ALAM, Natthanan SANGSRIRATANAKUL, Katsuhiro NAKAJIMA, Minori KITAZAWA, Mari OTA, Chiharu TOYOFUKU, Masashi YAMADA, Chanathip THAMMAKARN, Dany SHOHAM and Kazuaki TAKEHARA Journal of Veterinary Medical Science. 2016 Jul; 78(7): 1123–1128. Inactivation of bacteria on surfaces by sprayed slightly acidic hypochlorous acid water: in vitro experiments.
16. Geun Woo Park,Deyanna M. Boston,Julie A. Kase,Mark N. Sampson and Mark D. Sobsey. Applied Environmental Microbiology. 2007 Jul. Evaluation of Liquid- and Fog-Based Application of Sterilox Hypochlorous Acid Solution for Surface Inactivation of Human Norovirus.
17. Thomas Clasen, Paul Edmondson. International Journal of Hygiene and Environmental Health 209 (2006) 173–181: Sodium dichloroisocyanurate (NaDCC) tablets as an alternative to sodium hypochlorite for the routine treatment of drinking water at the household level.
18. Anagnostopoulos AG, Rong A, Miller D, Tran AQ, Head T, Lee MC, Lee WW. Dermatologic Surgery 2018 Dec.; 0.01% Hypochlorous Acid as an Alternative Skin Antiseptic: An In Vitro Comparison.
19. Hakim H, Thammakarn C, Suguro A, Ishida Y, Nakajima K, Kitazawa M, Takehara K. Avian Disases. 2015 Dec.; Aerosol Disinfection Capacity of Slightly Acidic Hypochlorous Acid Water Towards Newcastle Disease Virus in the Air: An In Vivo Experiment.
©2016 - 2021 HOCl Trust for Hygiene and Safer Water - Charity All Rights Reserved Registered Charity Number: 1165940 Terms & Conditions Privacy Policy
This website uses cookies to provide social media features and to analyse our traffic, and to allow you to complete functions on our website like completing forms. By clicking 'Accept' you agree to our use of cookies.
Learn more